Advertising Claims: Substantiation and False Advertising Exposure

An advertising claim is regulated twice over. The Federal Trade Commission asks whether the advertiser had adequate support in hand before the claim ran, and whether the advertisement is likely to mislead a reasonable consumer about something material. Separately, a competitor injured by the claim can sue in federal court under the Lanham Act and ask for money.

The two systems overlap but do not merge. An advertiser can survive a competitor's suit and still face an agency investigation, or clear a regulatory review and lose a case brought by the company whose sales it took. Compliance work has to satisfy both.

The claim is what consumers hear

The first mistake in advertising review is analysing the words instead of the message. Deception analysis looks at the net impression of the advertisement as a whole — headline, imagery, demonstration, testimonial, and fine print together — and asks what a consumer acting reasonably under the circumstances would take away.

That means implied claims count. A weight-loss product photographed beside a tape measure and a plate of vegetables is making a claim about results even if no sentence says so. A cleaning product shown removing a stain in five seconds is claiming that performance. A supplement page that lists studies next to a benefit statement is implying that those studies support that benefit for that product.

Disclaimers rarely rescue a misleading main message. A qualification has to be clear and conspicuous, close to the claim it modifies, in a form consumers actually encounter on the device they are using, and it cannot contradict the headline. "Results not typical" beneath a dramatic before-and-after does not cure the impression the images create.

Puffery — subjective, exaggerated praise no reasonable consumer would treat as a factual representation — sits outside this framework. "The world's most comfortable chair" is generally puffery. "Rated most comfortable by 9 out of 10 orthopaedic surgeons" is a factual claim requiring exactly the survey it describes. The line is not about enthusiasm; it is about whether the statement is capable of being proved false.

Reasonable basis, before the claim runs

The substantiation doctrine is simple to state and demanding in practice: an advertiser making an objective claim must possess and rely upon a reasonable basis for that claim at the time it is made. Support assembled after an inquiry arrives is not a defence, because the violation is making the claim without support.

How much support is reasonable depends on the claim. Where an advertisement states the level of proof — "clinically proven", "laboratory tested", "studies show" — the advertiser must have proof at that stated level. Where it does not, the amount is judged against factors the FTC has applied for decades: the type of product, the type of claim, the benefits of a truthful claim, the cost of developing substantiation, the consequences of a false claim, and the amount of substantiation experts in the field would consider reasonable. Health, safety, and efficacy claims sit at the demanding end, and the Commission's guidance for health-related products, updated in December 2022, describes competent and reliable scientific evidence in terms that generally point toward well-controlled human clinical testing for claims about disease and bodily function.

Verify before relying: match the study to the claim line by line — same ingredient, same dose, same form, same population, same endpoint, same duration. Most substantiation failures are not missing evidence; they are evidence that supports a slightly different claim.

Endorsements, influencers, and reviews

Endorsements are treated as the advertiser's own claims. If an endorser says the product cured a condition, the advertiser needs substantiation for that as if it had said it. The FTC's Endorsement Guides, revised in 2023, also require clear and conspicuous disclosure of material connections between endorser and advertiser — payment, free product, employment, family relationships, or anything else that would affect how a consumer weighs the endorsement.

Related exposure has grown. The Commission has pursued practices involving suppressed negative reviews, fabricated positive reviews, undisclosed insider reviews, and purchased follower counts, and it issued notices of penalty offences on endorsement practices in 2021 that put many companies on formal notice of conduct it has found unlawful. Advertisers should assume that review and testimonial programmes are reviewed with the same seriousness as claims in a television spot.

Where an endorser's persona, voice, or likeness is used beyond the agreed scope, or where synthetic media reproduces a recognisable person, a separate state-law right of publicity claim can arise — that terrain is covered in commercial use of name, image, voice, and likeness. And where marketing material reuses someone else's photographs, music, or footage, the copyright analysis runs alongside the advertising one; see applying the four fair use factors.

The competitor's claim under Section 43(a)

Section 43(a) of the Lanham Act creates a private right of action against a false or misleading description of fact in commercial advertising or promotion that misrepresents the nature, characteristics, qualities, or geographic origin of goods or services. It is a competitor's tool, not a consumer's: the Supreme Court held in 2014 in Lexmark v. Static Control that a plaintiff must allege an injury to a commercial interest in reputation or sales proximately caused by the deception.

A claimant typically must show a false or misleading statement of fact in commercial advertising, actual deception or a tendency to deceive a substantial segment of the audience, materiality to purchasing decisions, interstate commerce, and injury. The evidentiary burden splits along a familiar line. A literally false statement can be proved from the advertisement itself, and courts may presume deception. A statement that is literally true but misleading requires extrinsic proof of what consumers actually understood, which in practice means a properly designed consumer survey — expensive, attackable, and often the real battleground.

Remedies are substantial: injunctive relief, the defendant's profits, the plaintiff's damages, costs, and in exceptional cases attorneys' fees, with statutory authority to adjust profits awards where the amount is inadequate or excessive. Corrective advertising is available in appropriate cases. Because a competitor's suit can also be provoked by an aggressive enforcement letter, sequencing matters — see how demand letters create risk.

The enforcement landscape, as of 2026

Two developments shape current FTC practice and should be stated with their dates. In 2021 the Supreme Court held in AMG Capital Management v. FTC that Section 13(b) of the FTC Act does not authorise the Commission to obtain equitable monetary relief, which removed the agency's fastest route to consumer redress. The Commission responded by leaning on other authorities — administrative proceedings, rule violations that carry civil penalties, and its penalty offence authority, under which a company that knowingly engages in conduct the Commission has previously determined unlawful in a litigated order can face civil penalties.

Several newer rulemakings in the advertising space have been challenged in court, and at least one significant rule was set aside on appeal during 2025. Anyone building a compliance programme on a specific FTC rule should confirm its current status on the Commission's own business guidance pages rather than relying on commentary written when the rule was announced.

State law adds a third layer that does not move with federal doctrine. Every state has a consumer protection statute, many allow private suits with statutory damages and fee-shifting, and consumer class actions over labelling and pricing claims are filed continuously. A claim can be defensible under federal advertising standards and still generate a class action in a single state.

Building a file that survives a challenge

• Write down the claim as consumers will hear it, including implied messages, before reviewing the evidence.
• Assemble substantiation before dissemination and date it. Keep protocols, raw data, and the expert's reasoning, not just the summary.
• Record the review decision, including claims that were rejected or narrowed, and who approved the final version.
• Re-verify comparative claims whenever the competitor changes its product, and diary the recheck.
• Keep the assets consumers actually saw — screenshots, creative versions, placement dates — because the advertisement in the record decides the case.
• Put claim-support and disclosure obligations in agency and influencer contracts, with audit rights and an indemnification that survives termination.
• Monitor endorser posts and review platforms; a documented monitoring programme is itself evidence of good faith.

Where claims involve algorithmic or automated systems — accuracy rates, "AI-powered" performance, or personalised results — the substantiation question is the same but the evidence is harder to preserve, because models change. Vendor contracts should require documentation of model performance claims and the right to obtain testing data; related terms are covered in contracting with AI vendors.

Questions the desk gets

Do we need substantiation for a claim in a sales email or a social post?

Yes. The obligation attaches to the claim, not to the medium or the budget. Commercial advertising and promotion under the Lanham Act reaches communications disseminated to the relevant purchasing public, and FTC deception analysis applies wherever a claim reaches consumers — packaging, a landing page, a sales deck used with customers, a podcast read, or a founder's own social account.

Our competitor's ad is misleading but not literally false. Is that worth pursuing?

It is actionable, but the cost profile changes. Without literal falsity you generally need extrinsic evidence — a consumer survey designed to show what the audience actually took away — and the defence will attack the survey's design, universe, and controls. That is a meaningful budget item, which is why misleading-impression cases are often taken to a self-regulatory forum or a platform first.

Is "#1 rated" safe if a review site says so?

Only if the underlying rating means what the ad implies. Identify the source, the date, the category, and the methodology in the claim itself, and keep the supporting page. Ratings that come from a paid placement, a category the consumer would not expect, or a survey the advertiser commissioned without disclosure invite both an agency and a competitor challenge.

Can we be liable for what an influencer says on their own account?

Yes, where the relationship makes the endorsement the advertiser's message. Providing product, payment, scripts, or affiliate compensation creates a material connection that must be disclosed and makes the endorser's factual claims your claims. The controls that matter are contractual instruction, training, monitoring, and a documented process for correcting posts quickly.

Does an agency review protect us if the claim turns out to be wrong?

Internal or agency legal review is useful evidence of good faith, and it often prevents the problem entirely, but it does not create immunity. The obligation is possession of a reasonable basis, and no review process substitutes for evidence that actually supports the claim. Where the agency drafted the claim, the contract should say who bears the loss.

Sequencing the work

Write the claim first, in the words a consumer would use to repeat it. Then find the evidence that supports that exact statement, and if the evidence supports something narrower, change the claim rather than the interpretation. Date and file the support before the campaign runs.

Build the same discipline into the paperwork around the campaign: agency and influencer agreements that assign responsibility, monitoring that produces records, and a re-verification diary for comparative claims. If you are on the receiving end of a competitor's campaign, pick the forum before drafting anything, because the choice between a federal complaint, a self-regulatory challenge, and a letter changes what you need to prove and what you can win. Related brand, media, and enforcement work sits on the Intellectual Property & Media desk. This brief is general information about federal advertising law, not legal advice about a specific campaign.